Header Logo

Connection

ELIAS JOSEPH JABBOUR to Base Pair Mismatch

Back to Details
This is a "connection" page, showing publications ELIAS JOSEPH JABBOUR has written about Base Pair Mismatch.
ELIAS JOSEPH JABBOUR
Connection Strength
0.017
Base Pair Mismatch
  1. Phase I study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, combined with cytarabine in patients with refractory leukemia. Clin Cancer Res. 2005 Nov 01; 11(21):7817-24.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.